Successful Treatment of Recurrent Clostridioides difficile Infection Using a Novel, Drinkable, Oral Formulation of Fecal Microbiota.|https://dx.doi.org/10.1007/s10620-024-08351-7
Low-risk pneumatosis intestinalis in the pediatric surgical population.|https://dx.doi.org/10.1007/s00383-024-05642-y
